Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 21 Jan 2026 for Acumen Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleJames J. Doherty
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
James J. Doherty: trading record in brief
All filings by James J. Doherty on record concern Acumen Pharmaceuticals, Inc., in the capacity of senior executive. Between 6 January 2025 and 16 January 2026, the trades on record add up to 3 filings.
No open-market purchase appears, only 1 sale worth €2,891. Other entries cover 2 share grants. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 21 January 2026, the filings show a share grant in Acumen Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James J. Doherty
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
166,867 shares0Common StockSEC:0001628280-26-002956:0
1,700 shares@ US$1.98790.0018% mcap50.0% of flowCommon StockSEC:0001628280-26-001636:0
62,600 shares0Common StockSEC:0001576885-25-000017:0
3 of 3 declarations
